相关实验视频

Updated: Jul 6, 2025

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

CXCR4/CXCL12轴:"旧"途径作为"新"目标,用于抗炎药物发现

Liuxin Lu^1,2, Junjie Li^1,2, Xiaoying Jiang^1,2

¹Department of Medicinal Chemistry, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.

Medicinal research reviews

|January 5, 2024

概括

研究人员正在探索CXC化学因受体4型 (CXCR4) /CXC动机化学因配体12 (CXCL12) 轴作为抗炎药物的新目标. 阻断这个轴可以缓解各种疾病的炎症反应.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

炎症是对刺激的关键生物反应,需要安全有效的抗炎治疗.
越来越多地认识到CXC化学因子受体4型 (CXCR4) /CXC动机化学因子连接体12 (CXCL12) 轴在炎症途径中的上游作用.
这个轴影响炎症细胞化学反应,影响疾病的进展.

研究的目的:

系统地审查CXCR4/CXCL12轴在20多种炎症性疾病中的作用.
分析这个轴对炎症有所贡献的机制.
讨论CXCR4抗剂的抗炎作用潜力.

主要方法:

文献综述和对CXCR4/CXCL12轴在炎症中的现有研究进行系统分析.
检查关于CXCR4抗剂的临床前和临床数据.
综合发现以阐明轴的作用和治疗影响.

主要成果:

在许多炎症条件下,CXCR4/CXCL12轴是炎症细胞迁移的关键调节者.
阻止CXCR4/CXCL12相互作用显示出缓解炎症过程的巨大潜力.
CXCR4对抗剂代表了管理炎症疾病的有前途的治疗策略.

结论:

CXCR4/CXCL12轴在各种炎症性疾病的发病过程中是一个关键的调解器.
准CXCR4/CXCL12轴为开发下一代抗炎疗法提供了一种新且有效的方法.
对CXCR4抗剂的进一步研究可能会为患有炎症疾病的患者提供更好的治疗方法.

关键词:

在CXCL12中,CXCL12是CXCL12中的一个.在CXCR4中,CXCR4是CXCR4.化学物质是化学物质,化学物质是化学物质.发现药物的发现.炎症性疾病是一种炎症性疾病.

更多相关视频

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...